Watson Pharmaceuticals (WPI) Misses Q3 EPS by 4c, Comments on Outlook

November 7, 2006 4:14 PM EST Send to a Friend
Watson Pharmaceuticals (NYSE: WPI) reports Q3 EPS of $0.31, 3 cents worse than estimates.(0.34) Revenues were $440.5 million vs ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login